Published spend transparency data requirements were introduced via the Open Payments program, as mandated in the Affordable Care Act, to raise awareness of the financial influence that drug and device manufacturers have on the so-called covered recipients (physicians and a defined set of teaching hospitals).
Signet Accel and Predixion Software Partner to Bring Joint Data Integration and Predictive Modeling to Healthcare Industry
Accenture (NYSE: ACN) and Duke University have formed an alliance focused on jointly developing new advanced analytics solutions to address real-world, client-specific business challenges. The Accenture and Duke University Analytics Research Program will have an initial focus on health management research.
“There are a number of Bayesian modelling packages available, but how do you know which one to use? This talk will take you through the positives and negatives of the major packages, focusing on the specifics of my work in health statistics, as well as providing a general overview of what these packages can do.”
Insilico Medicine to Utilize Deep Learning for Drug Repurposing and Discovery in Cancer and Age-Related Disease
Insilico Medicine, a bioinformatics company dedicated to drug discovery for cancer and aging, has launched its proprietary DeepPharma (TM) platform. DeepPharma utilizes the latest advances in deep learning to improve computer analysis of massive structured multi-omics data banks and millions of tissue-specific pathway activation profiles.